Account Info
Log Out
English
Back
Log in to access Online Inquiry
Back to the Top

$Cullinan Therapeutics (CGEM.US)$ NEWS Cullinan Therapeutics...

NEWS
Cullinan Therapeutics to Present Clinical Data from Phase 1 Study Evaluating Novel Anti-MICA/B Antibody, CLN-619, as Monotherapy and in Combination with a Checkpoint Inhibitor in Patients with Advanced Solid Tumors at ASCO 2024
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only. Read more
Translate
Report
7406 Views
Comment
Sign in to post a comment